Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer

Background This phase I, dose-finding study evaluated the maximum tolerated dose (MTD), safety, pharmacokinetics, and antitumor activity of sunitinib plus S-1/cisplatin in Japanese patients with advanced/metastatic gastric cancer. Patients and methods Patients received oral sunitinib on a continuous...

Descripción completa

Detalles Bibliográficos
Autores principales: Boku, Narikazu, Muro, Kei, Machida, Nozomu, Hashigaki, Satoshi, Kimura, Nobuyuki, Suzuki, Mie, Lechuga, Mariajose, Miyata, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Phase I Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945293/
https://www.ncbi.nlm.nih.gov/pubmed/23665950
http://dx.doi.org/10.1007/s10637-013-9948-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945293/
https://www.ncbi.nlm.nih.gov/pubmed/23665950
http://dx.doi.org/10.1007/s10637-013-9948-5

Ejemplares similares